SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2008-03-31
Filing Date Changed: 2008-05-15
Documents: 5
SEC Accession No.
0000812796-08-000026
Filing date: 2008-05-15
Accepted: 2008-05-15 16:15:05

Table of submitted documents:

Seq Type Document Size Description
1 10-Q dor10q1q2008.htm 538446 DOR 10Q 1Q 2008
2 EX-31.1 ceocert1q10q2008.htm 12371 CEO CERT
3 EX-31.2 cfocert1q10q2008.htm 13050 CFO CERT
4 EX-32.1 ceosox1q10q2008.htm 7347 CEO SOX CERT
5 EX-32.2 cfosox1q10q2008.htm 7256 CFO SOX CERT
0000812796-08-000026.txt 580080 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 08837853
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200
 Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628